Aspects of primary ovarian cancer in Jamaica
Persaud, V.
West Indian Medical Journal 26(2): 90-100
1977
ISSN/ISBN: 0043-3144 PMID: 195403 Document Number: 115430
Document emailed within 1 workday
Related Documents
Penault-Llorca, F.; Levrel, O.; Clémenson, A.; Kwiatkowski, F.; Pomel, C.; Fouilhoux, G.; De Latour, M.; Curé, H.; Déchelotte, P.; Fonck, Y.; Dauplat, J. 2000: Assessment of different histoprognosis grading systems for primary ovarian cancer: 100 patients given the same treatment for primary ovarian adenocarcinoma Journal de Gynecologie Obstetrique et Biologie de la Reproduction 29(6): 548-554Fukuyama, A.; Yokoyama, Y.; Wada, J.; Hashimoto, T.; Oda, T.; Sato, S.; Mizunuma, H. 2009: Two cases of ovarian cancer at an early stage incidentally detected using transvaginal ultrasonography in screening: importance of interval for ovarian cancer screening and selection of population with a high risk of ovarian cancer European Journal of Gynaecological Oncology 30(2): 208-210
Hartge, P.; Hayes, R.; Reding, D.; Sherman, M.E.; Prorok, P.; Schiffman, M.; Buys, S. 2000: Complex ovarian cysts in postmenopausal women are not associated with ovarian cancer risk factors: preliminary data from the prostate, lung, colon, and ovarian cancer screening trial American Journal of Obstetrics and Gynecology 183(5): 1232-1237
Kjaerbye-Thygesen, A.; Huusom, L.D.; Frederiksen, K.; Kjaer, S.K.üg. 2007: Primary ovarian cancer. a comparison of registrations in the Danish Cancer Registry and the Pathology Data Bank Ugeskrift for Laeger 169(1): 50-54
Pickel, J.H. 1983: New aspects in the therapy of ovarian cancer Fortschritte der Medizin 101(30): 1387-1389
Gasowska-Bodnar, A.; Bodnar, L.; Wcisło, G.B.; Jerzak, M.łg.M.; Szczylik, C.; Baranowski, W.ło. 2008: CA 125 regression after two cycles of neoadjuvant chemotherapy as prognostic factor in patients with advanced ovarian cancer and primary peritoneal serous cancer who underwent interval surgical cytoreduction Ginekologia Polska 79(2): 108-114
Iakymova, T.P.; Pavlova, T.D.; Kartashov, S.M.; Iakymov, D.I. 1996: The morphological aspects of a study of the efficacy of chemotherapy in ovarian cancer Likars'ka Sprava 1996(7-9): 103-106
Havrilesky, L.J.; Gierisch, J.M.; Moorman, P.G.; Coeytaux, R.R.; Urrutia, R.Peragallo.; Lowery, W.J.; Dinan, M.; McBroom, A.J.; Wing, L.; Musty, M.D.; Lallinger, K.R.; Hasselblad, V.; Sanders, G.D.; Myers, E.R. 2013: Oral contraceptive use for the primary prevention of ovarian cancer Evidence report/technology assessment 2013(212): 1-514
McGuire, W.P. 1998: Current aspects of adjuvant therapy of early stage ovarian cancer Zentralblatt für Gynakologie 120(3): 93-97
Sekine, M.; Yoshihara, K.; Tanaka, K. 2012: Clinical aspects of familial ovarian cancer - current status and issues in Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(4): 506-511
Lai, D.-M.; Liu, T.; Huang, Y.; Wang, L.-H.; Zhang, J.; Cheng, W.-W. 2009: Identification and characterization of ovarian cancer stem-like cells from primary tumor Zhonghua Fu Chan Ke Za Zhi 44(12): 936-940
Einhorn, N.; Bast, R.C.; Knapp, R.C.; Tjernberg, B.; Zurawski, V.R. 1986: Preoperative evaluation of serum CA 125 levels in patients with primary epithelial ovarian cancer Obstetrics and Gynecology 67(3): 414-416
Kushlinskiĭ, N.E.; Podistov, I.I.; Laktionov, K.P.; Karseladze, A.I.; Babkina, I.V.; Kerimova, G.I. 1997: Prostaglandins e in the primary tumor, metastases, and ascitic fluid of patients with ovarian cancer Biulleten' Eksperimental'noi Biologii i Meditsiny 123(1): 83-86
Van Nagell, J.R.; Kim, E.; Casper, S.; Primus, F.J.; Bennett, S.; DeLand, F.H.; Goldenberg, D.M. 1980: Radioimmunodetection of primary and metastatic ovarian cancer using radiolabeled antibodies to carcinoembryonic antigen Cancer Research 40(3): 502-506
Riedinger, J.M.; Eche, N.; Basuyau, J.P.; Daver, A.; Touzery, C.; Mayer, F.; Coudert, B.; Fargeot, P.; Chauffert, B.; de Gislain, C.; Zanetta, S. 2002: Interpretation of the CA125 kinetics during first line chemotherapy of the ovarian cancer: methodological aspects and characteristic profiles Annales de Biologie Clinique 60(2): 183-191
Suzuki, M.; Sekiguchi, I.; Tamada, T.; Sakurabayashi, I.; Kawai, T. 1985: Clinical evaluation of a cancer antigen CA125 associated with ovarian cancer. (III) Serum CA125 levels in patients with ovarian cancer and other gynecological tumors Rinsho Byori. Japanese Journal of Clinical Pathology 33(2): 173-177
Rose, P.G.; Hunter, R.E. 1994: Advanced ovarian cancer in a woman with a family history of ovarian cancer, discovered at referral for prophylactic oophorectomy. A case report Journal of Reproductive Medicine 39(11): 908-910
Tanaka, K. 1989: Ovarian cancer--assessment of methods for cytogenetic analysis and chromosome aberrations found in ovarian cancer Rinsho Byori. Japanese Journal of Clinical Pathology Spec no 80: 268-280
Matsui, K.; Mori, T.; Sawada, M.; Kuroboshi, H.; Tatsumi, H.; Yoshioka, T.; Akiyama, M.; Yamamoto, T.; Iwasaku, K.; Kitawaki, J. 2014: Evaluation of primary prophylaxis with granulocyte colony-stimulating factor for epithelial ovarian cancer European Journal of Gynaecological Oncology 35(1): 48-51
Neubauer, H.; Stefanova, M.; Solomayer, E.; Meisner, C.; Zwirner, M.; Wallwiener, D.; Fehm, T. 2008: Predicting resistance to platinum-containing chemotherapy with the ATP tumor chemosensitivity assay in primary ovarian cancer Anticancer Research 28(2a): 949-955